These findings collectively reveal that KLF9 suppresses HCC risk factors by maintaining redox homeostasis and inhibiting inflammatory pathways, suggesting a broader tumor-suppressive function in cancers linked to metabolic dysfunction (29). Here, KLF9 is linked to hepatocellular carcinoma.